{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:55:36Z","timestamp":1781643336985,"version":"3.54.5"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum W\u00fcrzburg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Electroconvulsive therapy (ECT) is a highly effective treatment option for treatment-resistant psychiatric disorders. Seizure duration and the postictal suppression index (psi) have been suggested as markers for treatment outcome. As concomitant psychopharmacological medication can affect seizure threshold, understanding its effects on seizure quality could help optimize ECT. The aim of the analyses was to investigate associations between serum concentrations of psychopharmacological drugs and seizure duration and psi.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 302 ECT sessions in 87 patients were analyzed. Associations between serum concentrations of psychiatric drugs and seizure duration and psi were investigated using multiple linear regression models corrected for age, sex, stimulation side, the interaction number of ECT session:stimulus, as well as seizure-threshold-lowering comedication with clustered standard errors at patient level to account for intra-group correlation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Four substances demonstrated effects on ECT quality. Norquetiapine serum concentrations were negatively associated with seizure duration, whereas mirtazapine\u2009+\u2009N-desmethylmirtazapine serum concentrations showed a positive association. Psi was positively associated with sum serum concentrations of amitriptyline and risperidone. Sensitivity analyses point on robust results for quetiapine and amitriptyline.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These findings provide first evidence that serum concentrations of amitriptyline and quetiapine may influence seizure quality, suggesting potential for individualized optimization of ECT parameters. For clozapine, despite its seizure threshold-lowering effect, our data indicate that therapeutic-range concentrations do not increase the risk for excessively prolonged seizures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial number<\/jats:title>\n                    <jats:p>not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12888-026-07981-7","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T10:27:04Z","timestamp":1773743224000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between serum concentrations of psychotropic drugs and seizure quality during ECT treatment"],"prefix":"10.1186","volume":"26","author":[{"given":"Maike","family":"Scherf-Clavel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg C.","family":"Ziegler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"von Broen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Walther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,17]]},"reference":[{"key":"7981_CR1","doi-asserted-by":"publisher","first-page":"5905","DOI":"10.3390\/ijms26125905","volume":"26","author":"E Fetahovic","year":"2025","unstructured":"Fetahovic E, Janjic V, Muric M, Jovicic N, Radmanovic B, Rosic G, Selakovic D, Filipovic M, Muric N. Neurobiological mechanisms of electroconvulsive therapy: molecular perspectives of brain stimulation. Int J Mol Sci. 2025;26:5905.","journal-title":"Int J Mol Sci"},{"key":"7981_CR2","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/S0140-6736(03)12705-5","volume":"361","author":"UER Group","year":"2003","unstructured":"Group UER. Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet. 2003;361:799\u2013808.","journal-title":"Lancet"},{"key":"7981_CR3","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41386-023-01677-2","volume":"49","author":"ZD Deng","year":"2024","unstructured":"Deng ZD, Robins PL, Regenold W, Rohde P, Dannhauer M, Lisanby SH. How electroconvulsive therapy works in the treatment of depression: is it the seizure, the electricity, or both? Neuropsychopharmacology. 2024;49:150\u201362.","journal-title":"Neuropsychopharmacology"},{"key":"7981_CR4","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1056\/NEJMra2034954","volume":"386","author":"RT Espinoza","year":"2022","unstructured":"Espinoza RT, Kellner CH. Electroconvulsive therapy. N Engl J Med. 2022;386:667\u201372.","journal-title":"N Engl J Med"},{"key":"7981_CR5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1055\/a-2195-1499","volume":"57","author":"S Breit","year":"2024","unstructured":"Breit S, Meyer A, Schmitt W, Bracht T, Walther S. The effect of electroconvulsive therapy on specific catatonia symptoms and predictors of late response. Pharmacopsychiatry. 2024;57:13\u201320.","journal-title":"Pharmacopsychiatry"},{"key":"7981_CR6","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1192\/bjo.2023.5","volume":"9","author":"A Nygren","year":"2023","unstructured":"Nygren A, Reutfors J, Brandt L, Boden R, Nordenskjoeld A, Tiger M. Response to electroconvulsive therapy in treatment-resistant depression: nationwide observational follow-up study. Bjpsych Open. 2023;9:e35.","journal-title":"Bjpsych Open"},{"key":"7981_CR7","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","volume":"163","author":"AJ Rush","year":"2006","unstructured":"Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, Niederehe G, Thase ME, Lavori PW, Lebowitz BD, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR*D report. Am J Psychiat. 2006;163:1905\u201317.","journal-title":"Am J Psychiat"},{"key":"7981_CR8","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1097\/YCT.0000000000001034","volume":"40","author":"D Zilles-Wegner","year":"2024","unstructured":"Zilles-Wegner D, Kellner CH, Sartorius A. Electroconvulsive therapy and its new competitors. J Ect. 2024;40:e31\u20132.","journal-title":"J Ect"},{"key":"7981_CR9","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.jad.2022.12.144","volume":"326","author":"MAJT Blanken","year":"2023","unstructured":"Blanken MAJT, Oudega M, Hoogendoorn AW, Sonnenberg CS, Rhebergen D, Klumpers UMH, Van Diermen L, Birkenhager T, Schrijvers D, Redlich R, et al. Sex-specifics of ECT outcome. J Affect Disorders. 2023;326:243\u20138.","journal-title":"J Affect Disorders"},{"key":"7981_CR10","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/acps.13134","volume":"141","author":"CH Kellner","year":"2020","unstructured":"Kellner CH, Obbels J, Sienaert P. When to consider electroconvulsive therapy (ECT). Acta Psychiat Scand. 2020;141:304\u201315.","journal-title":"Acta Psychiat Scand"},{"key":"7981_CR11","doi-asserted-by":"publisher","first-page":"91","DOI":"10.4088\/JCP.10m05973gry","volume":"72","author":"L Hausner","year":"2011","unstructured":"Hausner L, Damian M, Sartorius A, Fr\u00f6lich L. Efficacy and cognitive side effects of electroconvulsive therapy (ECT) in depressed elderly inpatients with coexisting mild cognitive impairment or dementia. J Clin Psychiat. 2011;72:91\u20137.","journal-title":"J Clin Psychiat"},{"key":"7981_CR12","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jagp.2025.06.021","volume":"34","author":"CH Kellner","year":"2026","unstructured":"Kellner CH, Sartorius A, Espinoza RT. The evidence base for electroconvulsive therapy (ECT) in geriatric depression. Am J Geriatr Psychiatry. 2026;34:134\u20135.","journal-title":"Am J Geriatr Psychiatry"},{"key":"7981_CR13","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.jagp.2022.05.010","volume":"30","author":"S Lambrichts","year":"2022","unstructured":"Lambrichts S, Wagenmakers MJ, Vansteelandt K, Obbels J, Schouws SNTM, Verwijk E, van Exel E, Bouckaert F, Vandenbulcke M, Schrijvers D, et al. Long-term outcome following electroconvulsive therapy for late- life depression: five-year follow- up data from the MODECT study. Am J Geriat Psychiat. 2022;30:1283\u201394.","journal-title":"Am J Geriat Psychiat"},{"key":"7981_CR14","doi-asserted-by":"crossref","unstructured":"Kassar O, Makhlouf HA, Mansour MEM, Sartorius A. Long-term dementia risk following electroconvulsive therapy: A GRADE-assessed systematic review and meta-analysis. Int Psychogeriatr 2025:100159.","DOI":"10.1016\/j.inpsyc.2025.100159"},{"key":"7981_CR15","unstructured":"Bundes\u00e4rztekammer (B\u00c4K). Kassen\u00e4rztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der wissenschaftlichen medizinischen fachgesellschaften (AWMF). S3-leitlinie nationale versorgungsleitlinie unipolare depression. Langfassung, Version 3.2. Accessed September 2025: https:\/\/register.awmf.org\/de\/leitlinien\/detail\/nvl-005."},{"key":"7981_CR16","unstructured":"Deutsche gesellschaft f\u00fcr psychiatrie und psychotherapie. Psychosomatik und nervenheilkunde e V (DGPPN), Herausgeber f\u00fcr die leitliniengruppe. S3-leitlinie schizophrenie. Langfassung vom 15.0.2025; Version 4.0. Accessed October 2025: https:\/\/www.awmf.org\/leitlinien\/detail\/ll\/038-009.html."},{"key":"7981_CR17","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1177\/07067437241303031","volume":"70","author":"SN Vigod","year":"2025","unstructured":"Vigod SN, Frey BN, Clark CT, Grigoriadis S, Barker LC, Brown HK, Charlebois J, Dennis CL, Fairbrother N, Green SM, et al. Canadian network for mood and anxiety treatments 2024 clinical practice guideline for the management of perinatal mood, anxiety, and related disorders: guide de pratique 2024 du canadian network for mood and anxiety treatments pour le traitement des troubles de l\u2019humeur, des troubles anxieux et des troubles connexes p\u00e9rinatals. Can J Psychiatry. 2025;70:429\u201389.","journal-title":"Can J Psychiatry"},{"key":"7981_CR18","doi-asserted-by":"crossref","unstructured":"Ingram WM, Weston C, Dar Lu W, Hodge C, Poler SM, Nahi F, Larson S. Factors affecting electroconvulsive therapy ictal outcomes: duration and postictal suppression. AMIA Jt Summits Transl Sci Proc. 2019; 2019:672\u20139.","DOI":"10.1101\/433789"},{"key":"7981_CR19","doi-asserted-by":"publisher","first-page":"e2422738","DOI":"10.1001\/jamanetworkopen.2024.22738","volume":"7","author":"C Gillving","year":"2024","unstructured":"Gillving C, Ekman CJ, Hammar A, Landen M, Lundberg J, Movahed Rad P, Nordanskog P, von Knorring L, Nordenskjold A. Seizure duration and electroconvulsive therapy in major depressive disorder. JAMA Netw Open. 2024;7:e2422738.","journal-title":"JAMA Netw Open"},{"key":"7981_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clinph.2023.01.008","volume":"148","author":"JCM Pottkamper","year":"2023","unstructured":"Pottkamper JCM, Verdijk JPAJ, Stuiver S, Aalbregt E, Schmettow M, Hofmeijer J, van Waarde JA, van Putten MJAM. Seizure duration predicts postictal electroencephalographic recovery after electroconvulsive therapy-induced seizures. Clin Neurophysiol. 2023;148:1\u20138.","journal-title":"Clin Neurophysiol"},{"key":"7981_CR21","doi-asserted-by":"publisher","first-page":"e12544","DOI":"10.1111\/appy.12544","volume":"15","author":"ME Langroudi","year":"2023","unstructured":"Langroudi ME, Shams-Alizadeh N, Maroufi A, Rahmani K, Rahchamani M. Association between postictal suppression and the therapeutic effects of electroconvulsive therapy: a systematic review. Asia Pac Psychiatry. 2023;15:e12544.","journal-title":"Asia Pac Psychiatry"},{"key":"7981_CR22","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.3390\/jcm11051440","volume":"11","author":"V Moulier","year":"2022","unstructured":"Moulier V, Guehl J, Eveque-Mourroux E, Quesada P, Rotharmel M. A retrospective study of postictal suppression during electroconvulsive therapy. J Clin Med. 2022;11:1440.","journal-title":"J Clin Med"},{"key":"7981_CR23","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1038\/s41380-024-02803-2","volume":"30","author":"D Loef","year":"2025","unstructured":"Loef D, Hoogendoorn AW, Somers M, Mocking RJT, Scheepens DS, Scheepstra KWF, Blijleven M, Hegeman JM, van den Berg KS, Schut B, et al. A prediction model for electroconvulsive therapy effectiveness in patients with major depressive disorder from the Dutch ECT Consortium (DEC). Mol Psychiatr. 2025;30:1915\u201324.","journal-title":"Mol Psychiatr"},{"key":"7981_CR24","doi-asserted-by":"publisher","first-page":"647","DOI":"10.4306\/pi.2017.14.5.647","volume":"14","author":"SH Chi","year":"2017","unstructured":"Chi SH, Jeong HG, Lee S, Oh SY, Kim SH. Effects of psychotropic drugs on seizure threshold during electroconvulsive therapy. Psychiat Invest. 2017;14:647\u201355.","journal-title":"Psychiat Invest"},{"key":"7981_CR25","doi-asserted-by":"publisher","first-page":"1341508","DOI":"10.3389\/fpsyt.2024.1341508","volume":"15","author":"S Mohamad","year":"2024","unstructured":"Mohamad S, Trumm S, Treskatsch S, Drevs A, Bajbouj M, Wiedemann L. The influence of concomitant antidepressant and antipsychotic medication on antidepressant effect and seizure duration of electroconvulsive therapy. Front Psychiatry. 2024;15:1341508.","journal-title":"Front Psychiatry"},{"key":"7981_CR26","first-page":"385","volume":"57","author":"G Gazdag","year":"2004","unstructured":"Gazdag G, Barna I, Iv\u00e1nyi Z, Tolna J. The impact of neuroleptic medication on seizure threshold and duration in electroconvulsive therapy. Ideggyogy Sz. 2004;57:385\u201390.","journal-title":"Ideggyogy Sz"},{"key":"7981_CR27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1055\/s-0043-116492","volume":"51","author":"C Hiemke","year":"2018","unstructured":"Hiemke C, Bergemann N, Clement HW, Conca A, Deckert J, Domschke K, Eckermann G, Egberts K, Gerlach M, Greiner C, et al. Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017. Pharmacopsychiatry. 2018;51:9\u201362.","journal-title":"Pharmacopsychiatry"},{"key":"7981_CR28","unstructured":"INSTAND Gesellschaft zur. F\u00f6rderung der Qualit\u00e4tssicherung in medizinischen Laboratorien e V. Accessed 10 February 2020: https:\/\/www.instand-ev.de\/ueber-instand-ev\/instand-ev.html."},{"key":"7981_CR29","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1007\/s11096-023-01588-8","volume":"45","author":"M Scherf-Clavel","year":"2023","unstructured":"Scherf-Clavel M, Frantz A, Eckert A, Weber H, Unterecker S, Deckert J, Reif A, Hahn M. Effect of CYP2D6 pharmacogenetic phenotype and phenoconversion on serum concentrations of antidepressants and antipsychotics: a retrospective cohort study. Int J Clin Pharm-Net. 2023;45:1107\u201317.","journal-title":"Int J Clin Pharm-Net"},{"key":"7981_CR30","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1055\/a-1872-0613","volume":"55","author":"M Scherf-Clavel","year":"2022","unstructured":"Scherf-Clavel M, Weber H, Wurst C, Stonawski S, Hommers L, Unterecker S, Wolf C, Domschke K, Rost N, Br\u00fcckl T, et al. Effects of pharmacokinetic gene variation on therapeutic drug levels and antidepressant treatment response. Pharmacopsychiatry. 2022;55:246\u201354.","journal-title":"Pharmacopsychiatry"},{"key":"7981_CR31","doi-asserted-by":"publisher","first-page":"983","DOI":"10.3390\/pharmaceutics17080983","volume":"17","author":"M Scherf-Clavel","year":"2025","unstructured":"Scherf-Clavel M, Fekete S, Gerlach M, Correll CU, Plener P, Fegert JM, Karwautz A, Heuschmann P, Banaschewski T, Briegel W, et al. Sex-specific differences in antidepressant and antipsychotic treatment outcomes and serum levels in children and adolescents. Pharmaceutics. 2025;17:983.","journal-title":"Pharmaceutics"},{"key":"7981_CR32","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.1600-0447.1977.tb03566.x","volume":"56","author":"G D\u2019Elia","year":"1977","unstructured":"D\u2019Elia G, Frederiksen SO, Raotma H, Widepalm K. Comparison of fronto-frontal and temporo-parietal unilateral ECT. Acta Psychiatr Scand. 1977;56:233\u20139.","journal-title":"Acta Psychiatr Scand"},{"key":"7981_CR33","unstructured":"RCoreTeam. R. A language and environment for statistical computing. Vienna, Austria: R foundation for statistical computing; 2014. R Core Team https:\/\/www.R-project.org\/."},{"key":"7981_CR34","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2165\/00002018-200225020-00004","volume":"25","author":"F Pisani","year":"2002","unstructured":"Pisani F, Oteri G, Costa C, Di Raimondo G, Di Perri R. Effects of psychotropic drugs on seizure threshold. Drug Saf. 2002;25:91\u2013110.","journal-title":"Drug Saf"},{"key":"7981_CR35","doi-asserted-by":"publisher","first-page":"127","DOI":"10.9740\/mhc.n127568","volume":"2","author":"CY Oh","year":"2012","unstructured":"Oh CY, Bainbridge J. Lowering the seizure threshold associated with antidepressants, stimulants, antipsychotics, and others. Mental Health Clinician. 2012;2:127\u20138.","journal-title":"Mental Health Clinician"},{"key":"7981_CR36","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, M\u00fcller M. pROC: an open-source package for R and S\u2009+\u2009to analyze and compare ROC curves. BMC Bioinformatics. 2011;12:77.","journal-title":"BMC Bioinformatics"},{"key":"7981_CR37","unstructured":"Khan M, Brandenburger T, ROCit. Performance assessment of binary classifier with visualization. In., 2.1.2 edn; 2024."},{"key":"7981_CR38","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3390\/futurepharmacol2030018","volume":"2","author":"M Ortega-Ruiz","year":"2022","unstructured":"Ortega-Ruiz M, Soria-Chacartegui P, Villapalos-Garc\u00eda G, Abad-Santos F, Zubiaur P. The pharmacogenetics of treatment with quetiapine. Future Pharmacol. 2022;2:276\u201386.","journal-title":"Future Pharmacol"},{"key":"7981_CR39","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.neubiorev.2004.06.008","volume":"28","author":"FS Giorgi","year":"2004","unstructured":"Giorgi FS, Pizzanelli C, Biagioni F, Murri L, Fornai F. The role of norepinephrine in epilepsy: from the bench to the bedside. Neurosci Biobehav Rev. 2004;28:507\u201324.","journal-title":"Neurosci Biobehav Rev"},{"key":"7981_CR40","first-page":"20","volume":"4","author":"E Ozdemir","year":"2024","unstructured":"Ozdemir E. Adrenergic receptor system as a pharmacological target in the treatment of epilepsy (Review). Med Int (Lond). 2024;4:20.","journal-title":"Med Int (Lond)"},{"key":"7981_CR41","first-page":"203","volume":"19","author":"AM \u0160imundi\u0107","year":"2009","unstructured":"\u0160imundi\u0107 AM. Measures of diagnostic accuracy: basic definitions. Ejifcc. 2009;19:203\u201311.","journal-title":"Ejifcc"},{"key":"7981_CR42","first-page":"116","volume":"13","author":"A Farah","year":"1997","unstructured":"Farah A. Mirtazapine and ECT combination therapy. Convuls Ther. 1997;13:116\u20137.","journal-title":"Convuls Ther"},{"key":"7981_CR43","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1097\/YCT.0b013e3181e63346","volume":"27","author":"TC Li","year":"2011","unstructured":"Li TC, Shiah IS, Sun CJ, Tzang RF, Huang KC, Lee WK. Mirtazapine relieves post-electroconvulsive therapy headaches and nausea: a case series and review of the literature. J ect. 2011;27:165\u20137.","journal-title":"J ect"},{"key":"7981_CR44","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1080\/15622970500213871","volume":"7","author":"TC Baghai","year":"2006","unstructured":"Baghai TC, Marcuse A, Brosch M, Schule C, Eser D, Nothdurfter C, Steng Y, Noack I, Pietschmann K, Moller HJ, et al. The influence of concomitant antidepressant medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy. World J Biol Psychiatry. 2006;7:82\u201390.","journal-title":"World J Biol Psychiatry"},{"key":"7981_CR45","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s11940-011-0127-8","volume":"13","author":"KH Noe","year":"2011","unstructured":"Noe KH, Locke DE, Sirven JI. Treatment of depression in patients with epilepsy. Curr Treat Options Neurol. 2011;13:371\u20139.","journal-title":"Curr Treat Options Neurol"},{"key":"7981_CR46","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s40263-014-0222-y","volume":"29","author":"AM Williams","year":"2015","unstructured":"Williams AM, Park SH. Seizure associated with clozapine: incidence, etiology, and management. CNS Drugs. 2015;29:101\u201311.","journal-title":"CNS Drugs"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-026-07981-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-026-07981-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-026-07981-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:18:48Z","timestamp":1781641128000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12888-026-07981-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7981"],"URL":"https:\/\/doi.org\/10.1186\/s12888-026-07981-7","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,17]]},"assertion":[{"value":"28 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in the analysis involving human participants were in accordance with the ethical standards of the institutional research committee (ethics committee of the University of Wuerzburg; approval-number: 2025-239-dvhd) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consents to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"According to the approval of the ethics committee of the University of Wuerzburg (approval-number: 2025-239-dvhd) consent to participate is not applicable for retrospective studies.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"MSC received honorarium from Rovi. SW received honoraria from Neurolite. GCZ and MvB declare that they have no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"290"}}